Literature DB >> 8803673

Structural basis of autoimmunity against G protein coupled membrane receptors.

J Hoebeke1.   

Abstract

The structural basis of the function of G protein coupled membrane receptors will be considered taking the beta 2-adrenergic receptor as model. The immunogenicity and antigenicity of the same receptor will be studied to examine the immunological properties of the G protein coupled membrane receptors. From the two first parts will be derived the conditions which could lead to the building-up of a functional autoimmune response. Finally, the possible application of the structural knowledge on antibody-receptor interactions will be discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8803673     DOI: 10.1016/0167-5273(96)02586-7

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Pathophysiological role of autoantibodies against G-protein-coupled receptors in the cardiovascular system.

Authors:  Wolfgang Schulze; Rudolf Kunze; Gerd Wallukat
Journal:  Exp Clin Cardiol       Date:  2005

2.  Implications of a vasodilatory human monoclonal autoantibody in postural hypotension.

Authors:  Hongliang Li; Jonathan Zuccolo; David C Kem; Caitlin Zillner; Jiyeon Lee; Kenneth Smith; Judith A James; Madeleine W Cunningham; Xichun Yu
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

3.  Experimental study on AT1-receptor-peptide-induced myocardial immune damage in rat.

Authors:  Y Luo; Y Liao; M Wang; Y Wei; J Dong; I Wang; Y Lu
Journal:  J Tongji Med Univ       Date:  2001

4.  Adoptive passive transfer of rabbit beta1-adrenoceptor peptide immune cardiomyopathy into the Rag2-/- mouse: participation of the ER stress.

Authors:  Jiahao Liu; Weike Mao; Chikao Iwai; Shuji Fukuoka; Raju Vulapalli; Huanlei Huang; Tingchung Wang; Virendra K Sharma; Shey-Shing Sheu; Michael Fu; Chang-Seng Liang
Journal:  J Mol Cell Cardiol       Date:  2007-11-24       Impact factor: 5.000

Review 5.  Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function.

Authors:  L R Herda; S B Felix; F Boege
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

6.  Novel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat model.

Authors:  Valérie Boivin; Niklas Beyersdorf; Dieter Palm; Viacheslav O Nikolaev; Angela Schlipp; Justus Müller; Doris Schmidt; Vladimir Kocoski; Thomas Kerkau; Thomas Hünig; Georg Ertl; Martin J Lohse; Roland Jahns
Journal:  PLoS One       Date:  2015-02-20       Impact factor: 3.240

7.  Autoantibodies against M5-muscarinic and beta1-adrenergic receptors in periodontitis patients.

Authors:  Isabel Scherbaum; Harald Heidecke; Kübra Bunte; Ulrike Peters; Thomas Beikler; Fritz Boege
Journal:  Aging (Albany NY)       Date:  2020-08-28       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.